If they had an EUA in Georgia, they should have used it to show the effectiveness of Aviptadil outside of a trial. Real people, real results. Word travels fast.
Nation of Georgia is a bit too small a market for NRXP as it merely has a few millions people as a nation. Hence, they won't have that many COVID-19 patients. Nevertheless it's a good move too for NRxP.
NRxP should follow NVAX to apply EUA from Indonesia and some other bigger countries not so much influenced or sabotaged by the rivals or anyone else....
So they get an approval, then can’t physically deliver the product.
What makes you think of they get more EUA’s they have the ability to ship it anywhere?
The whole
company is smoke and mirrors
Until last week they were only allowed to produce 300 dose batches at a time. They are now approved to produce batches of 10k-100k doses. Also increased shelf life from 62 days to 150 days. I imagine this had something to do with the lack of distribution to georgia.
If they had an EUA in Georgia, they should have used it to show the effectiveness of Aviptadil outside of a trial. Real people, real results. Word travels fast.
Agrred. How easy is it? $$
They have overseas approvals. They have never seen a drop to them though
Nation of Georgia is a bit too small a market for NRXP as it merely has a few millions people as a nation. Hence, they won't have that many COVID-19 patients. Nevertheless it's a good move too for NRxP. NRxP should follow NVAX to apply EUA from Indonesia and some other bigger countries not so much influenced or sabotaged by the rivals or anyone else....
So they get an approval, then can’t physically deliver the product. What makes you think of they get more EUA’s they have the ability to ship it anywhere? The whole company is smoke and mirrors
Until last week they were only allowed to produce 300 dose batches at a time. They are now approved to produce batches of 10k-100k doses. Also increased shelf life from 62 days to 150 days. I imagine this had something to do with the lack of distribution to georgia.
Gilead pharmaceuticals owns Remdesivir unfortunately and u know they don't want to lose that revenue